FAM48A-ATP8A2 Fusion FISH Probe
The FAM48A-ATP8A2 Fusion FISH Probe is used to confirm a fusion of the FAM48A and ATP8A2 genes. The fusion of the FAM48A and ATP8A2 genes has been associated with Sarcoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| FAM48A-ATP8A2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| FAM48A-ATP8A2-20-AQAQ | 20 (40 μL) | 200 μL |
|
ATP8A2 Gene Summary
The protein encoded by this gene is a member of the P4 ATPase family of proteins, which are thought to be involved in a process called lipid flipping, whereby phospholipids are translocated inwards from the exoplasmic leaflet to the cytosolic leaflet of the cell membrane, which aids in generating and maintaining asymmetry in membrane lipids. This protein is predicted to contain an E1 E2 ATPase, a haloacid dehalogenase-like hydrolase (HAD) domain, and multiple transmembrane domains. Associations between this protein and cell cycle control protein 50A are important for translocation of phosphatidylserine across membranes. Mutations in this gene have been associated with a syndrome (CAMRQ4) characterized by cerebellar ataxia and cognitive disabilities. In addition, a translocation breakpoint within this gene was observed in an individual with neurological dysfunction. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2017]
Gene Name: ATPase Phospholipid Transporting 8A2
Chromosome: CHR13: 25946208 -26595420
Locus: 13q12.13
Gene Diseases
The FAM48A ATP8A2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Sarcoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|